Additional Combination Treatment with Vectibix for Metastatic Colorectal Cancer (mCRC)
The Old Drug: VECTIBIX
The Company: AMGEN
Colon cancer is easy to cure when discovered early. Missing the diagnosis of early colon cancer could result in cancer growth, direct spread, distal metastasis and death. In spite of the tremendous improvement of treatments, advanced colon cancer is still winning most of the battles in the ongoing war against it. Among the existing targeted products, Vectibix (panitumumab) is the first fully human monoclonal anti-EGFR antibody the FDA approved in 2006 as monotherapy for . . .
This content is for paid subscribers.
Today’s Highlights July 3, 2017